Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect [Yahoo! Finance]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $194.69 million, and the earnings are expected to come in at $1.02 per share. The full year 2024's revenue is expected to be $746.61 million and the earnings are expected to be $3.41 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 3 Warning Signs with AMPH. Over the past 90 days, revenue estimates for Amphastar Pharmaceuticals Inc ( NASDAQ:AMPH ) for the full year 2024 have declined from $746.79 million to $746.61 million, while the estimates for 2025 have increased from $802.34 million to $818.89 million. Earnings estimates for the full year 2024 have decreased from $3.65 per share to $3.41 per share, and for 2025, they have increased from $4.28 per share to $4.34 per share. In the previous quarter of 2024-06-30, Amphastar Pharmaceuticals Inc's ( NASDAQ:AMPH ) actual revenue was $182.39 million, which beat analysts' revenue expectations of $170.94 million by 6.7%. Amphastar Ph
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $55.00 price target on the stock.MarketBeat
- Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceAccesswire
- Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ... [Yahoo! Finance]Yahoo! Finance
- Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024Accesswire
AMPH
Earnings
- 11/6/24 - Beat
AMPH
Sec Filings
- 11/13/24 - Form 4
- 11/13/24 - Form 4
- 11/12/24 - Form 4
- AMPH's page on the SEC website